Dexamethasone-induced hyperglycaemia in COVID-19: Glycaemic profile in patients without diabetes and factors associated with hyperglycaemia

AIMS: To evaluate glycaemic profiles of COVID-19 patients without diabetes receiving dexamethasone and determine factors associated with hyperglycaemia. METHODS: All subjects without pre-existing diabetes receiving dexamethasone 6 mg for COVID-19 in a non-critical care setting were identified. Gluco...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhou, Yoon Ji J, Hor, Amanda, Wang, Mawson, Wu, Yu-Fang, Jose, Suja, Chipps, David R, Cheung, N Wah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651935/
https://www.ncbi.nlm.nih.gov/pubmed/36375566
http://dx.doi.org/10.1016/j.diabres.2022.110151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651935/
https://www.ncbi.nlm.nih.gov/pubmed/36375566
http://dx.doi.org/10.1016/j.diabres.2022.110151

Ejemplares similares